510(k) K233932

Alinity i Toxo IgM by Abbott Laboratories — Product Code LGD

K233932 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "Alinity i Toxo IgM". The FDA issued a decision of Substantially Equivalent on August 30, 2024. The device falls under product code LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii), a Class II device regulated under 21 CFR 866.3780. Abbott Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 30, 2024
Date Received
December 14, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Device Class
Class II
Regulation Number
866.3780
Review Panel
MI
Submission Type